ALPINE Archives - Medical Conferences

Zanubrutinib wins battle of BTK inhibitors in relapsed or refractory CLL/SLL

Presented By

Prof. Jennifer Brown, Dana Farber Cancer Institute, MA, USA

Trial

Phase 3, ALPINE

Conference

ASH 2022

Type

Peer-reviewed article

20 February 2023 11:40

Presented By

Prof. Peter Hillmen, University of Leeds, UK

Trial

Phase 3, ALPINE

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:08

site created by:

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com